α-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population

Neuroscience Letters

Volumn 240, Issue 2, 1998, Pages 107-109

  Ezquerra, Mario ^a   Blesa, Rafael ^a   Tolosa, Eduard ^a   Ballesta, Francisca ^a   Oliva, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer's disease; ApoE; Apolipoprotein E; Genes; Antichymotrypsin; Antichymotrypsin polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHYMOTRYPSIN INHIBITOR; DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SPAIN;

EID: 0032498132     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00924-5     Document Type: Article

References (29)

1. Abraham C.R., Selkoe D.J., Potter H. Immunochemical identification of serine protease inhibitor α1-antitrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Adroer R., Santacruz P., Blesa R., Lopez-Pousa S., Ascaso C., Oliva R. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci. Lett. 189:1995;182-186.
3. Bergem A.L.M., Lannfelt L. Apolipoprotein E and the interaction with α1-antichymotrypsin as risk factors in Alzheimer's disease and vascular dementia. Finding from a twin study, Neurol. Aging. 17(Suppl.):1996;S61.
4. Blesa R., Adroer R., Santacruz P., Ascaso C., Tolosa E., Oliva R. High apolipoprotein E allele frequency in age related memory decline. Ann. Neurol. 39:1996;548-552.
5. Byth B.C., Billingsley G.D., Cox D.W. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and unique haplotype associated with α1-antitrypsin deficiency. Am. J. Hum. Genet. 55:1994;126-133.
6. Corder E.H., Saunders A.M., Strittmatter W.J., Shmechel P.C., Gaskell P.C., Small G.H., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
7. Ezquerra M., Blesa R., Tolosa E., Lopez Pousa S., Aguilar M., Peña J., Van Broeckhoven C., Ballesta F., Oliva R. The genotype 2/2 of the presenilin-1 is decreased in Spanish early-onset Alzheimer's disease. Neurosci. Lett. 227:1997;201-204.
8. Fraser P.E., Nguyen J.T., McLachlan D.R., Abraham C.R., Kirschener D.A. α1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disagregation in vitro. J. Neurochem. 61:1993;298-305.
9. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-709.
10. Haines J.L., Pritchard M.L., Saunders A.M., Schildkraut J.M., Growdon J.H., Gaskell P.C., Farrer L.A., Auerbach S.A., Gusella J.F., Locke P.A., Rosi M.L., Yamaoka L., Small G.W., Conneally P.M., Roses A.D., Pericack-Vance M.A. No genetic effect of α1-antichymotrypsin in Alzheimer disease. Genomics. 33:1996;53-56.
11. Higuchi M., Arai H., Nakagawa T., Higuchi S., Muramatsu T., Matsushita S., Kosaka Yi., Itho M., Sasaki H. Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha (1) antichymotrypsin type A allele in Alzheimer's disease. NeuroReport. 8(12):1997;2639-2643.
12. Kamboh M.I., Sanghera D.K., Ferrell R.E., DeKosky S.T. APOE*4 associated Alzheimer's disease risk is modified by α-antichymotrypsin polymorphism. Nature Genet. 10:1995;486-488.
13. Kevin M., Morgan L., Carpenter K., Lowe J., Lam L., Cave S., Xuereb J., Wischik C., Harrington C., Kalsheker N.A. Microsatellite polymorphism of the α1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum. Genet. 99:1996;27-31.
14. Kowalska A., Danker-Hopfe H., Wender M., Florczak J., Walter H. Association between the PI*M3 allele of α1-antitrypsin and Alzheimer's disease? A preliminary report, Hum. Genet. 98:1996;744-746.
15. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C., Jondro P.D., Schmidt S.D., Wang K., Crowley A., Fu Y., Guerelte S., Galas D., Nemens E., Wijsman E., Bird T., Schellenberg G., Tanzi R. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
16. Mayeux R., Stern Y., Oittman R., Tatemichi T.K., Tang M.-X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
17. Muramatsu T., Matsushita S., Arai H., Sasaki H., Higuchi S. α-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease. J. Neurol. Trans. 103:1996;1205-1210.
18. Nacmias B., Tedde A., Latorraca S., Piacentini S., Braco L., Amaducci L., Guarniere B.M., Petrucci C., Ortenzi L., Sorbi S. Apolipoprotein E and α-antichymotrypsin gene polymorphism in Alzheimer's disease. Ann. Neurol. 40:1996;678-680.
19. Poller W., Faber J.P., Weidinger S., Tief K., Scholtz S., Fisher M., Olek K., Kirchgesser M., Heidtmann H.H. A leucine-to-proline substitution causes a defective α-antichymotrypsinn allele associated with familial obstructive lung disease. Genomics. 17(3):1993;740-743.
20. Saunders A., Strittmatter W., Schemechel D., St George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Craper D.R., Alberts M.J., Hulette C., Crain B., Golgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
21. Sherrington R., Rogaev E., Llang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
22. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvensen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
23. Talbot C., Houlden H., Craddock N., Crook R., Hutton M., Lendon C., Prihar G., Morris J.C., Hardy J., Goate A. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. NeuroReport. 7:1996;534-536.
24. Thome J., Baumer A., Kornhuber J., Rosler R., Riederer P. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk for Alzheimer's syndrome. J. Neurol. Transm. 102:1995;207-212.
25. Van Broeckhoven C., Backhovens H., Cruts M., Martin J., Crook R., Houlden H., Hardy J. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer disease. Neurosci. Lett. 169:1994;179-180.
26. Van Broeckhoven C. Presenilin and Alzheimer's disease. Nature Genet. 11:1995;230-232.
27. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one stage PCR. Lancet. 337:1991;1158-115928.
28. Wragg, M., Hutton, M., Talbot, C. and The Alzheimer's disease Collaborative Group, Genetic association between intron polymorphism in presenilin-1 and late-onset Alzheimer's disease, Lancet, 347 (1996) 509-512.
29. Yoshiiwa A., Kamino K., Nishiwaki Y., Yamamoto H., Kobayashi T., Miki T., Ogihara T. α-Antichymotrypsin gene as a risk factor for late-onset Alzheimer disease in Japanese population. Am. J. Hum. Genet. 59(Suppl.):1996;A244.